Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Vivos Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 18 | 29 | +11 |
| Shares | 820.7K | 2.35M | +1.53M (+186.0%) |
| Value | $5.45M | $11.7M | +$6.24M (+114.4%) |
New holders (16)
Institutions that held Vivos Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 383,891 | $1.90M | 0.00% |
| Penn Capital Management Co Inc | 223,403 | $1.11M | 0.11% |
| Bard Associates Inc | 215,500 | $1.07M | 0.35% |
| Archon Capital Management LLC | 215,000 | $1.06M | 0.23% |
| Perkins Capital Management Inc | 162,500 | $804.0K | 0.46% |
| Walleye Capital LLC | 150,000 | $743.0K | 0.03% |
| Millrace Asset Group, Inc. | 93,993 | $465.0K | 0.24% |
| K2 Principal Fund, L.P. | 64,746 | $320.0K | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 37,551 | $186.0K | 0.00% |
| Aperture Investors, LLC | 32,611 | $161.0K | 0.02% |
| WMS Partners, LLC | 16,667 | $153.0K | 0.02% |
| Renaissance Technologies LLC | 19,200 | $95.0K | 0.00% |
| IHT Wealth Management, LLC | 12,330 | $61.0K | 0.00% |
| Northern Trust Corp | 11,483 | $57.0K | 0.00% |
| Global Retirement Partners, LLC | 570 | $3.00K | 0.00% |
| Toth Financial Advisory Corp | 200 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Vivos Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| K.J. Harrison & Partners Inc | 45,419 | $302.0K |
| Creative Planning | 31,000 | $206.0K |
| Citadel Advisors LLC | 15,846 | $105.0K |
| Alpha Paradigm Partners, LLC | 9,921 | $66.0K |
| Tower Research Capital LLC (TRC) | 366 | $2.00K |